Literature DB >> 596954

Penicillamine in seronegative polyarthritis.

I A Jaffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 596954      PMCID： PMC1000173          DOI： 10.1136/ard.36.6.593

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  [Letter: Ankylosing spondylarthritis. Failure of treatment by D-penicillamine].

Authors:  A P Leca; J P Camus
Journal:  Nouv Presse Med       Date:  1975-01-11

2.  Failure of D-penicillamine to affect peripheral joint involvement in ankylosing spondylitis or HLA B27-associated arthropathy.

Authors:  H A Bird; A S Dixon
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103
  2 in total
  3 in total

Review 1.  Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; M Dougados; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

Review 2.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

3.  Ankylosing spondylitis. Current drug treatment.

Authors:  J T Gran; G Husby
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.